Your browser doesn't support javascript.
loading
Is re-challenge still an option as salvage therapy in multiple myeloma? The case of REal-life BOrtezomib re-Use as secoND treatment for relapsed patients exposed frontline to bortezomib-based therapies (the REBOUND Study).
Musto, Pellegrino; Simeon, Vittorio; Cascavilla, Nicola; Falcone, Antonietta; Petrucci, Maria Teresa; Cesini, Laura; Di Raimondo, Francesco; Conticello, Concetta; Ria, Roberto; Catalano, Lucio; Salvatore, Dalila; Mastrullo, Lucia; Gagliardi, Alfredo; Villani, Oreste; Pietrantuono, Giuseppe; D'Arena, Giovanni; Mansueto, Giovanna; Bringhen, Sara; Genuardi, Mariella; Di Renzo, Nicola; Reddiconto, Giovanni; Fragasso, Alberto; Caravita, Tommaso; Scapicchio, Daniele; Marziano, Gioacchino; Boccadoro, Mario; Mangiacavalli, Silvia; Corso, Alessandro.
Afiliação
  • Musto P; Haematology and Stem Cell Transplantation Unit, IRCCS-CROB, Referral Cancer Center of Basilicata, Rionero in Vulture, PZ, Italy. p.musto@crob.it.
  • Simeon V; Department of Public, Clinical and Preventive Medicine, Medical Statistics Unit, University of Campania Luigi Vanvitelli, Naples, Italy.
  • Cascavilla N; Haematology and SCT Unit, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, FG, Italy.
  • Falcone A; Haematology and SCT Unit, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, FG, Italy.
  • Petrucci MT; Haematology Unit, Department of Cellular Biotechnologies and Haematology, La Sapienza University, Rome, Italy.
  • Cesini L; Haematology Unit, Department of Cellular Biotechnologies and Haematology, La Sapienza University, Rome, Italy.
  • Di Raimondo F; Haematology Unit, Azienda Policlinico OVE, University of Catania, Catania, Italy.
  • Conticello C; Haematology Unit, Azienda Policlinico OVE, University of Catania, Catania, Italy.
  • Ria R; Internal Medicine and Clinical Oncology, AOU Policlinico Giovanni XXIII, University of Bari, Bari, Italy.
  • Catalano L; Haematology and SCT Unit, Federico II University, Naples, Italy.
  • Salvatore D; Haematology and SCT Unit, Federico II University, Naples, Italy.
  • Mastrullo L; Haematology Unit, S. Gennaro Hospital, Naples, Italy.
  • Gagliardi A; Haematology Unit, S. Gennaro Hospital, Naples, Italy.
  • Villani O; Haematology and Stem Cell Transplantation Unit, IRCCS-CROB, Referral Cancer Center of Basilicata, Rionero in Vulture, PZ, Italy.
  • Pietrantuono G; Haematology and Stem Cell Transplantation Unit, IRCCS-CROB, Referral Cancer Center of Basilicata, Rionero in Vulture, PZ, Italy.
  • D'Arena G; Haematology and Stem Cell Transplantation Unit, IRCCS-CROB, Referral Cancer Center of Basilicata, Rionero in Vulture, PZ, Italy.
  • Mansueto G; Haematology and Stem Cell Transplantation Unit, IRCCS-CROB, Referral Cancer Center of Basilicata, Rionero in Vulture, PZ, Italy.
  • Bringhen S; Haematology Unit, AOU Città della Salute e della Scienza, Turin, Italy.
  • Genuardi M; Haematology Unit, AOU Città della Salute e della Scienza, Turin, Italy.
  • Di Renzo N; Haematology and SCT Unit, Vito Fazzi Hospital, Lecce, Italy.
  • Reddiconto G; Haematology and SCT Unit, Vito Fazzi Hospital, Lecce, Italy.
  • Fragasso A; Haematology Unit, Madonna delle Grazie Hospital, Matera, Italy.
  • Caravita T; Haematology Unit, S. Eugenio Hospital, Rome, Italy.
  • Scapicchio D; Management Control Unit, IRCCS-CROB, Referral Cancer Center of Basilicata, Rionero in Vulture, PZ, Italy.
  • Marziano G; Scientific Direction, IRCCS-CROB, Referral Cancer Center of Basilicata, Rionero in Vulture, PZ, Italy.
  • Boccadoro M; Haematology Unit, AOU Città della Salute e della Scienza, Turin, Italy.
  • Mangiacavalli S; Haematology Unit, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy.
  • Corso A; Haematology Unit, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy.
Ann Hematol ; 98(2): 361-367, 2019 Feb.
Article em En | MEDLINE | ID: mdl-30353388

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Terapia de Salvação / Bortezomib / Mieloma Múltiplo Tipo de estudo: Observational_studies / Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Terapia de Salvação / Bortezomib / Mieloma Múltiplo Tipo de estudo: Observational_studies / Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article